| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.12B | 43.79B | 40.47B | 42.55B | 34.23B | 29.67B |
| Gross Profit | 7.34B | 7.38B | 7.44B | 7.68B | 5.73B | 4.36B |
| EBITDA | 5.02B | 5.09B | 5.25B | 6.35B | 4.89B | 4.15B |
| Net Income | 1.70B | 1.19B | 1.79B | 2.22B | 1.02B | 373.65M |
Balance Sheet | ||||||
| Total Assets | 42.33B | 47.72B | 43.89B | 42.82B | 39.36B | 36.91B |
| Cash, Cash Equivalents and Short-Term Investments | 9.50B | 9.62B | 9.68B | 10.33B | 8.55B | 6.82B |
| Total Debt | 4.19B | 6.78B | 4.09B | 4.08B | 6.71B | 8.20B |
| Total Liabilities | 11.80B | 14.57B | 12.83B | 12.67B | 14.04B | 14.19B |
| Stockholders Equity | 24.04B | 25.96B | 24.05B | 22.72B | 18.58B | 16.50B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.11B | 846.36M | 4.89B | 3.55B | 714.42M |
| Operating Cash Flow | 0.00 | 4.72B | 4.42B | 7.42B | 4.98B | 2.37B |
| Investing Cash Flow | 0.00 | -7.42B | -3.13B | -2.82B | -1.11B | -1.70B |
| Financing Cash Flow | 0.00 | 1.74B | -2.10B | -3.66B | -2.67B | -1.39B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥159.56B | 8.33 | ― | 4.47% | 1.64% | 19.87% | |
75 Outperform | ¥212.54B | 19.50 | 7.50% | 5.39% | -1.82% | 23.07% | |
74 Outperform | ¥71.93B | 9.43 | 5.20% | 3.67% | 6.47% | 40.87% | |
73 Outperform | ¥86.59B | 5.74 | ― | 4.95% | -1.72% | 8.59% | |
66 Neutral | ¥9.94B | 8.81 | ― | 2.91% | 8.19% | -33.62% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | ¥317.30B | 135.95 | ― | 1.93% | <0.01% | -83.75% |